Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 2
2010 1
2011 1
2012 1
2015 3
2016 1
2017 2
2018 1
2019 1
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.
Nolan JM, Power R, Howard AN, Bergin P, Roche W, Prado-Cabrero A, Pope G, Cooke J, Power T, Mulcahy R. Nolan JM, et al. J Alzheimers Dis. 2022;90(1):233-249. doi: 10.3233/JAD-220556. J Alzheimers Dis. 2022. PMID: 36093704 Clinical Trial.
BACKGROUND: Preliminary work by our center has reported behavior and functional benefits in patients with Alzheimer's disease (AD) following targeted micronutritional supplementation. OBJECTIVE: To build on the existing exploratory research and investi …
BACKGROUND: Preliminary work by our center has reported behavior and functional benefits in patients with Alzheimer's disea
Effect of nutrition in Alzheimer's disease: A systematic review.
Xu Lou I, Ali K, Chen Q. Xu Lou I, et al. Front Neurosci. 2023 May 4;17:1147177. doi: 10.3389/fnins.2023.1147177. eCollection 2023. Front Neurosci. 2023. PMID: 37214392 Free PMC article.
BACKGROUND AND OBJECTIVE: Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by declining cognitive ability. ...In contrast, the Mediterranean diet, ketogenic diet, and supplementation with omega-3
BACKGROUND AND OBJECTIVE: Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by d …
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
Freund-Levi Y, Basun H, Cederholm T, Faxén-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jönhagen M. Freund-Levi Y, et al. Int J Geriatr Psychiatry. 2008 Feb;23(2):161-9. doi: 10.1002/gps.1857. Int J Geriatr Psychiatry. 2008. PMID: 17582225 Clinical Trial.
BACKGROUND: Epidemiological and animal studies have suggested that dietary fish or fish oil rich in omega-3 fatty acids (omega3), docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), may have effects in psychiatric and behavioral symptoms in …
BACKGROUND: Epidemiological and animal studies have suggested that dietary fish or fish oil rich in omega-3 fatty ac
Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.
Jernerén F, Cederholm T, Refsum H, Smith AD, Turner C, Palmblad J, Eriksdotter M, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Freund-Levi Y. Jernerén F, et al. J Alzheimers Dis. 2019;69(1):189-197. doi: 10.3233/JAD-181148. J Alzheimers Dis. 2019. PMID: 30958356 Clinical Trial.
BACKGROUND: Trials of supplementation with omega-3 fatty acids (omega3-FAs) in patients with mild cognitive impairment or Alzheimer's disease (AD) have produced inconsistent effects on cognitive decline. ...OBJECTIVE: …
BACKGROUND: Trials of supplementation with omega-3 fatty acids (omega3-FAs) in patients with mild
Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease.
Wood AHR, Chappell HF, Zulyniak MA. Wood AHR, et al. Eur J Nutr. 2022 Mar;61(2):589-604. doi: 10.1007/s00394-021-02655-4. Epub 2021 Aug 15. Eur J Nutr. 2022. PMID: 34392394 Free PMC article. Review.
METHODS: Studies were identified in PubMed and Scopus using the search terms "omega-3 fatty acids", "Alzheimer's disease" and "cognition", along with common variants. ...The protective effects LC omega3 PUFAs on cognitive function …
METHODS: Studies were identified in PubMed and Scopus using the search terms "omega-3 fatty acids", "Alzheime
Mitochondrial Pharmaceutics: A New Therapeutic Strategy to Ameliorate Oxidative Stress in Alzheimer's Disease.
Ajith TA, Padmajanair G. Ajith TA, et al. Curr Aging Sci. 2015;8(3):235-40. doi: 10.2174/187460980803151027115147. Curr Aging Sci. 2015. PMID: 25986626 Review.
Association between amyloid-beta (Abeta) toxicity, mitochondrial dysfunction, oxidative stress and neuronal damage has been demonstrated in the pathophysiology of Alzheimer's disease (AD). In the early stages of the disease, the defect in energy metabo …
Association between amyloid-beta (Abeta) toxicity, mitochondrial dysfunction, oxidative stress and neuronal damage has been demonstrated in …
Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia or Alzheimer's disease in older adults - any news?
Cederholm T. Cederholm T. Curr Opin Clin Nutr Metab Care. 2017 Mar;20(2):104-109. doi: 10.1097/MCO.0000000000000350. Curr Opin Clin Nutr Metab Care. 2017. PMID: 27977429 Review.
PURPOSE OF REVIEW: Twenty years of research indicates that fish and n-3 fatty acids (FAs), for example docosahexaenoic acid, may attenuate cognitive decline including Alzheimer's disease in older people. ...Still, a Cochrane review (using three …
PURPOSE OF REVIEW: Twenty years of research indicates that fish and n-3 fatty acids (FAs), for example docosahexaenoic acid, m …
Nutritional Intervention to Prevent Alzheimer's Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined.
Nolan JM, Mulcahy R, Power R, Moran R, Howard AN. Nolan JM, et al. J Alzheimers Dis. 2018;64(2):367-378. doi: 10.3233/JAD-180160. J Alzheimers Dis. 2018. PMID: 29945352 Clinical Trial.
BACKGROUND: A growing body of scientific evidence suggests that enrichment of certain nutritional compounds in the brain may reduce the risk of Alzheimer's disease (AD). OBJECTIVE: To investigate the impact of supplemental xanthophyll carotenoids plus …
BACKGROUND: A growing body of scientific evidence suggests that enrichment of certain nutritional compounds in the brain may reduce the risk …
The effects of long-term omega-3 fatty acid supplementation on cognition and Alzheimer's pathology in animal models of Alzheimer's disease: a systematic review and meta-analysis.
Hooijmans CR, Pasker-de Jong PC, de Vries RB, Ritskes-Hoitinga M. Hooijmans CR, et al. J Alzheimers Dis. 2012;28(1):191-209. doi: 10.3233/JAD-2011-111217. J Alzheimers Dis. 2012. PMID: 22002791 Review.
To date, only a few randomized clinical trials (RCTs) have investigated the effects of omega-3 fatty acids (FA) on Alzheimer's disease (AD). Some of these studies demonstrated that patients with very mild AD or mild c …
To date, only a few randomized clinical trials (RCTs) have investigated the effects of omega-3 fatty acids (FA) …
Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J. Freund-Levi Y, et al. Arch Neurol. 2006 Oct;63(10):1402-8. doi: 10.1001/archneur.63.10.1402. Arch Neurol. 2006. PMID: 17030655 Clinical Trial.
BACKGROUND: Epidemiologic and animal studies have suggested that dietary fish or fish oil rich in omega-3 fatty acids, for example, docosahexaenoic acid and eicosapentaenoic acid, may prevent Alzheimer disease (AD). OBJECTIVE: To determin …
BACKGROUND: Epidemiologic and animal studies have suggested that dietary fish or fish oil rich in omega-3 fatty acid
18 results